Under high DBP exposure, significant differences in various physiological responses were observed between the two cultivars, which might account for the variation in DBP accumulation.
At 60 ppm CO exposure, significant differences (p < 0.05) are observed in both tissue samples, compared to control tissue.
Taking into account the same degree of exposure, significant differences were found between the positive results using the 3 techniques.
Although MitoSOX Red fluorescence was higher following AngII exposure, no significant differences were noted across treatment conditions.
In relation to the DEE exposure, no significant differences were found, although tendencies toward upregulation of HO-1 protein were noted in the cerebral cortex and the hypothalamus.
Despite our finding significant correlations between inflammation and cumulative WTC exposure and significant differences in PSD between FDNY-FFs and TA-FFs, we could not detect a significant effect of cumulative WTC exposure on PSD.
For Mirex, WBC declined in the highest exposure; no significant differences were observed for p-p'-DDT or p-p'-DDE; and higher levels of WBC were observed at the highest exposure groups of serum trans-nonachlor and oxychlordane.
Interestingly, we observed a significant increase in CypA levels in the nucleus compared with control conditions, starting 6 h after onset of glutamate exposure, without significant differences in its cytosolic levels.
Body weight gain for control rats was similar to those exposed to DE. Whole-body plathysmography measurement of breathing parameters revealed rat strain-dependent but no exposure-related significant differences [see Supplemental Material, Figure 1 (http://www.ehponline.org/members/2008/11647/suppl.pdf)].
On the 14th day after exposure, no significant difference was found among all groups in their levels of GOT, GPT, urea, Cr, cholesterol, TG, total protein, and albumin (P > 0.05).
On the third day after exposure, no significant difference was found among all groups in terms of the glutamic oxaloacetic transaminase (GOT), glutamate pyruvate transaminase (GPT), urea, cholesterol, triacylglyceride (TG), blood glucose, total protein, and albumin levels (P > 0.05).
